Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Jumped Today


Shares of Moderna (NASDAQ: MRNA) rose on Wednesday after fellow drugmaker Pfizer (NYSE: PFE) reported strong sales of its COVID-19 vaccine and raised its full-year revenue forecast. As of 3:30 p.m. EDT, the biotechnology company's stock price was up more than 6%.

Pfizer generated $7.8 billion in coronavirus-related revenue in the second quarter. The healthcare giant now expects to deliver 2.1 billion doses and earn $33.5 billion in COVID-19 vaccine revenue in 2021, up from its prior estimate of $26 billion.

Investors bid up Moderna's shares following Pfizer's solid Q2 results. Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments